Manning Paul B

EDGAR CIK 0001494695

Taysha Gene Therapies, Inc. - TSHA

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
10% owner
Direct Buys
1
$3.00 M
1,333,333 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$2.06 M
750,000 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
05/30/2025
06/03/2025
Buy
750,000 @ $2.75
 $2,062,500 2,841,704 (35.86%) Indirect - See footnote
06/27/2024
07/01/2024
Buy
1,333,333 @ $2.25
 $2,999,999 1,333,333 (100.00%) Direct

Candel Therapeutics, Inc. - CADL

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$3.00 M
500,000 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
12/16/2024
12/18/2024
Buy
500,000 @ $6.00
 $3,000,000 1,142,406 (77.83%) Indirect - By Paul B. Manning Revocable Trust

Liquidia Corp - LQDA

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$3.00 M
337,078 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
09/12/2024
09/16/2024
Buy
337,078 @ $8.90
 $2,999,994 816,311 (70.34%) Indirect - See footnote